Hydrogen Medicine Could Transform Healthcare and Disrupt Drug Industry
- Authors
- Yuh Fukai
- Journal
- Molecular Hydrogen for Medicine: The Art of Ancient Life Revived
- Year
- 2020
- DOI
- 10.1007/978-981-15-7157-2_8
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Critical Illness
- Body System
- Multiple Systems
TL;DR
Scientists are discovering that a simple, cheap treatment using hydrogen might help treat tons of diseases, which is amazing for sick people but could mess up how drug companies make money.
Key Finding
__no_content__
Summary
This research analysis examines the future trajectory of molecular hydrogen medicine (MHM), which has primarily been used for critically ill patients and those with chronic diseases. The study suggests MHM will soon expand to treat many ordinary diseases due to its therapeutic benefits. However, the extremely low cost of hydrogen therapy presents a paradox: while it's beneficial for patients, it threatens traditional pharmaceutical business models that rely on expensive treatments. The research discusses how the development of molecular hydrogen medicine should proceed given these economic challenges, highlighting the need for new approaches to research and development in this emerging field.
Abstract
The application of MHM has so far been largely limited to patients under grave condition or suffering from chronic diseases, but in the near future, it will be extended to many ‘ordinary’ diseases. Then, while the low cost of MHM is a godsend for patients, it will pose serious problems for pharmaceutical companies; the existing business model may fail in the face of MHM. How the R&D of MHM should be advanced under such conditions is discussed.